Please provide your email address to receive an email when new articles are posted on . The machine-learning model successfully identified all eyes with mild NPDR that progressed within 1 year. The ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Diabetes affects hundreds of millions of people worldwide, and one of its most feared complications is vision loss. High blood sugar over long periods can damage small blood vessels throughout the ...

Google has been busy recently. Just in the past week it has closed down its Google Fit website, launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool ...

STOCKHOLM — At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting, researchers discussed how insights into potential risk factors and new treatments could improve outcomes for ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

Intraretinal microvascular abnormalities (IRMAs) are abnormal branching, or dilation, of the blood vessels in the retina. It occurs as a complication of diabetic retinopathy. Diabetic retinopathy ...